Nkarta to Participate in March Investor Conferences

Company Overview - Nkarta, Inc. is a clinical-stage biotechnology company focused on developing engineered natural killer (NK) cell therapies for autoimmune diseases [2] - The company utilizes a combination of cell expansion, cryopreservation platforms, proprietary cell engineering technologies, and CRISPR-based genome engineering to create its therapies [2] Upcoming Events - Nkarta will participate in the TD Cowen 45th Annual Health Care Conference on March 3, 2025, at 3:10 p.m. ET for a fireside chat [1] - The company will also be present at the Leerink Partners 2025 Global Healthcare Conference on March 10, 2025, at 3:00 p.m. ET for another fireside chat [1] - Both events will be available via simultaneous webcast on Nkarta's website, with replays archived for approximately 90 days [1]